Aurobindo Pharma Ltd share price logo

Aurobindo Pharma Ltd

NSE: AUROPHARMA

BSE: 524804

Mid Cap

Healthcare Sector

Pharma Sector

₹1681.40

+21.50

(+1.30%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Aurobindo Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-50%

Searches for Aurobindo Pharma on INDmoney have decreased by 50% over the last 30 days.

Among the most traded stocks

172nd

Aurobindo Pharma was the 172nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

31 days

INDmoney investors hold Aurobindo Pharma shares for an average of 31 days.

Key Events for Aurobindo Pharma

Upcoming Events

Next Results Date
04/11/2026

Last Dividend Declared

₹4.00 per share, declared on 04/08/2025

View Dividend History

Aurobindo Pharma Stock Performance

as on October 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,647.20
    ₹1,687.00
    downward going graph

    2.03%

    Downside

    0.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,081.40
    ₹1,740.00
    downward going graph

    35.68%

    Downside

    3.49%

    Upside

    downward going graph

Aurobindo Pharma share price movements today

Previous Close
₹1,659.90
Open
₹1,652.00
Volume
9.53L
Upper Circuit
₹1,719.70
Lower Circuit
₹1,619.70
Day's Low - High
₹1,647.20 - ₹1,687.00
52 Week Low - High
₹1,081.40 - ₹1,740.00

Aurobindo Pharma Historical Returns

1 Month Return
-1.01 %
3 Month Return
+ 5.04 %
1 Year Return
+ 45.75 %
3 Year Return
+ 95.4 %
5 Year Return
+ 137.94 %

Aurobindo Pharma Fundamentals

as on October 30, 2026 at 4:01 pm IST

Market Cap

₹96,744.04 Cr

Return on Equity (ROE)

11.17

PE Ratio (TTM)

25.94

Return on capital employed (ROCE)

12.91

Industry PE ratio

51.39

Beta (LTM)

0.45

P/B Ratio

3.33

Dividend Yield

0.31

PEG Ratio

4.57

Quarterly Earnings Growth YOY

25.22

EPS (TTM)

60.31

Book Value

652.39

Aurobindo Pharma Stock Valuation

as on October 30, 2026 at 4:01 pm IST

Aurobindo Pharma in the last 5 years

  • Overview

  • Trends

Lowest (6.73x)

March 23, 2020

Today (25.94x)

October 29, 2026

Industry (51.39x)

October 29, 2026

Highest (27.59x)

December 21, 2023

LowHigh

Today’s Price to Earnings Ratio: 25.94x

Aurobindo Pharma Technical Analysis

Track how Aurobindo Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish12
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
1.27
Bullish
CCI (20)
74.53
Neutral
RSI (14)
85.01
Bearish
Momentum (10)
7.4
Bullish
ADI (14)
17.01
Neutral
Ultimate Oscillator (7,14,28)
93.4
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1673.3
Bullish
EMA (20)
1673.86
Bullish
VWMA (20)
1674.32
Bullish
SMA (50)
1672.67
Bullish
EMA (50)
1673.36
Bullish
SMA (200)
1676.79
Bullish
EMA (200)
1674.09
Bullish
KAMA (200)
1673.62
Bullish
DEMA (200)
1676.97
Bullish

Aurobindo Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aurobindo Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY96,744.0427.59%0.603,50233,653
Sanofi India Ltd image
Sanofi India Ltd
BUY7,379.04-12.3%0.003261,837
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,24,239.1027.24%0.695,02651,180
Abbott India Ltd image
Abbott India Ltd
BUY54,474.386.2%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY42,254.9511.49%0.561,0353,821
See all

Market expectation of Aurobindo Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

61.54%

Buy

19.23%

Hold

19.23%

Sell

Aurobindo Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
7,271.23
7,491.92
7,457.65
7,646.21
7,893.15
8,381.12
7,791.77
8,236.96
8,604.51
8,751.5
9,105.82
Other Income
162.52
135.62
220.93
136.3
158.88
134.81
107.22
122.25
188.01
117.04
264.23
Total Income
7,514.3
7,715.77
7,787.95
7,932.37
8,137.4
8,516.93
7,975.36
8,407.95
8,833.91
8,970.38
9,414.58
Expenses
5,753.06
6,042.11
5,948.84
6,229.93
6,400.54
6,622.39
6,265.11
6,607.6
6,937.89
7,102.99
7,311.01
Operating Profit
1,518.17
1,449.81
1,508.81
1,416.28
1,492.61
1,758.73
1,526.66
1,629.36
1,666.62
1,648.51
1,794.81
Operating Profit Margin %
20.88%
19.35%
20.23%
18.52%
18.91%
20.98%
19.59%
19.78%
19.37%
18.84%
19.71%
Profit Before Interest, Tax and Depreciation
1,761.24
1,673.66
1,839.11
1,702.44
1,736.86
1,894.54
1,710.25
1,800.35
1,896.02
1,867.39
2,103.57
Interest
75.55
89.43
111.04
112.7
118.48
115.02
97.75
95.24
92.77
98.21
101.66
Depreciation
423.27
354.33
404.18
382.28
418.53
444.43
405.7
429.19
464.73
478.57
486.82
Profit Before Tax
1,262.42
1,229.9
1,323.89
1,207.46
1,199.85
1,335.09
1,206.8
1,275.92
1,338.52
1,290.61
1,515.09
Tax Paid
322.45
322.55
405.67
390.51
354.28
432.26
382.6
427.79
428.72
369.77
483.06
Profit After Tax
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
1,032.03
Total Net profit including share of profit / Loss from associate company
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
1,032.03
EPS
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86
Actual EPS
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86
Adjusted EPS
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86
Diluted EPS
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86

Aurobindo Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
16,232.87
19,225.92
22,737.95
24,557.95
23,366.55
24,617.13
28,704.5
31,378.13
33,384.74
Other Income
105.12
118.36
86.2
3,195.42
320.35
290.59
557.38
621.85
493.61
Total Income
16,604.96
19,681.91
23,184.7
27,970.05
23,775.84
25,145.97
29,559.25
32,345.58
34,146.69
Expenses
12,728.08
15,759.95
18,315.2
19,496.58
19,227.94
21,148.41
23,367.89
25,172.63
26,872.68
Operating Profit
3,504.79
3,465.97
4,422.75
5,061.37
4,138.61
3,468.72
5,336.61
6,205.5
6,512.06
Operating Profit Margin %
21.59%
18.03%
19.45%
20.61%
17.71%
14.09%
18.59%
19.78%
19.51%
Profit Before Interest, Tax and Depreciation
3,876.88
3,921.96
4,869.5
8,473.47
4,547.9
3,997.56
6,191.36
7,172.95
7,274.01
Interest
77.71
162.66
159.77
74.49
48.64
140.48
289.71
457.24
383.97
Depreciation
557.97
667.95
966.71
1,055.38
1,126.52
1,244.58
1,521.66
1,649.42
1,778.19
Profit Before Tax
3,241.2
3,091.35
3,743.02
7,343.6
3,372.74
2,612.5
4,379.99
5,066.29
5,111.85
Tax Paid
818.28
726.85
913.51
2,009.77
725.63
684.85
1,211.02
1,582.72
1,608.88
Profit After Tax
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
Total Net profit including share of profit / Loss from associate company
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Actual EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Adjusted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Diluted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34

Aurobindo Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,419.76
3,278.58
1,954.52
1,650.97
4,381.28
3,329.05
5,016.48
2,386.75
2,434.52
3,924.62
5,526.37
Cash Flow from Investing Activities
-1,445.51
-1,787.18
-1,926.76
-2,904.39
-1,562.86
596.57
-3,211.36
-3,971.4
-4,241.78
-1,866.04
-2,629.61
Cash Flow from Financing Activities
365.44
-1,915.26
864.15
1,919.06
-1,947.18
-1,364.94
-2,969.27
1,814.41
800.42
119.78
-1,269.15
Net Cash Flow
339.69
-423.86
891.91
665.64
871.24
2,560.68
-1,164.15
229.76
-1,006.84
2,178.36
1,627.61

Aurobindo Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
51.83%
51.83%
51.8%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.88%
51.88%
DII
20.23%
23.28%
24.77%
25.13%
25.2%
26.23%
26.93%
27.6%
27.68%
25.87%
25.1%
24.42%
FII
0%
18.02%
16.73%
16.59%
16.29%
15.33%
14.37%
14.21%
13.94%
15.24%
16.38%
17.41%
Public
6.85%
6.87%
6.7%
6.46%
6.69%
6.61%
6.87%
6.38%
6.55%
7.08%
6.64%
6.29%
Total Outstanding Shares
58,59,38,609
58,59,38,609
58,59,38,609
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
57,53,77,895
57,53,77,895
Total Shareholders
2,41,944
2,44,575
2,38,622
2,48,488
2,57,962
2,69,323
2,72,208
2,47,662
2,36,859
2,41,298
2,39,073
2,33,737

Mutual Funds Buying / Exiting Aurobindo Pharma

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Aurobindo Pharma

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Aurobindo Pharma

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Quant Mid Cap Fund Growth Option Direct Plan

Quant Mid Cap Fund Growth Option Direct Plan

₹824.36 Cr

₹31.70 Cr (-3.70%)

10.71%

Aurobindo Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Aurobindo Pharma.

  • Aurobindo Pharma Ltd Earnings Results

    Aurobindo Pharma Ltd’s net profit jumped 25.2% since last year same period to ₹1,032.56Cr in the Q1 2026-2027. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 12.08% jump in its net profits since last 3-months.

    Read More

  • Aurobindo Pharma Ltd Dividends August,2025

    In the quarter ending June 2025, Aurobindo Pharma Ltd has declared dividend of ₹4.00 per share on 04 Aug 2025 - translating a dividend yield of 0.24%.

    Read More about Dividends

Indices Featuring Aurobindo Pharma Stock

Check stock indices that include Aurobindo Pharma.

NIFTY PHARMA

₹27,124.85

+414.05 (▲1.55%)

Nifty Healthcare

₹16,449.55

+255.65 (▲1.58%)

S&P BSE 150 MidCap

₹15,521.49

-140.25 (▲0.90%)

S&P BSE 250 LargeMidCap

₹10,155.34

-8.28 (▲0.08%)

S&P BSE MidCap Select

₹17,197.81

-109.65 (▲0.63%)

Nifty 200

₹13,183.95

+7.90 (▲0.06%)

Nifty Midcap 150

₹21,047.50

-197.80 (▲0.93%)

Nifty Midcap 100

₹57,301.25

-540.40 (▲0.93%)

BSE Healthcare

₹50,168.37

+474.08 (▲0.95%)

BSE 500

₹34,248.59

-103.74 (▲0.30%)

Nifty MidSmallcap 400

₹19,500.00

-256.25 (▲1.30%)

Nifty LargeMidcap 250

₹15,541.55

-47.05 (▲0.30%)

S&P BSE 400 MidSmallCap

₹11,628.38

-154.80 (▲1.31%)

Nifty Midcap 50

₹16,513.30

-143.10 (▲0.86%)

Nifty Midcap Sel

₹13,184.50

-196.55 (▲1.47%)

BSE 200

₹10,660.88

-5.83 (▲0.05%)

Nifty 500

₹21,895.90

-45.60 (▲0.21%)

Insights on Aurobindo Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, AUROPHARMA stock has moved up by 20.6%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 16.38% to 17.41% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, 824.75 Cr → 1.03K Cr (in ₹), with an average increase of 5.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 7.97K Cr → 9.41K Cr (in ₹), with an average increase of 4.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 520.3% return, outperforming this stock by 424.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 135.3% return, outperforming this stock by 89.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.88% of holdings in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.64% to 6.29% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 16.71% to 16.31% in Sep 2026 quarter

Aurobindo Pharma Stock Futures & Options Contracts

View the latest movement in Aurobindo Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Aurobindo Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 23 Nov ₹1680 Call
November 23, 2026
₹1680
₹46.8
9.65
25.98%
AUROPHARMA 23 Nov ₹1700 Call
November 23, 2026
₹1700
₹38.2
8.15
27.12%
AUROPHARMA 23 Nov ₹1660 Call
November 23, 2026
₹1660
₹56.9
10
21.32%
AUROPHARMA 23 Nov ₹1800 Call
November 23, 2026
₹1800
₹11.2
2.8
33.33%

Aurobindo Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 23 Nov Fut
November 23, 2026
-
₹1674.5
19.53
1.18%
AUROPHARMA 29 Dec Fut
December 29, 2026
-
₹1684
17.33
1.04%
AUROPHARMA 25 Jan Fut
January 25, 2027
-
₹1695.2
26.04
1.56%

About Aurobindo Pharma Ltd

Aurobindo Pharma Ltd is an Indian multinational pharmaceutical company incorporated in 1986. Aurobindo Pharma operates in several lines of business including APIs, generics, biosimilars, advanced drugs, and consumer healthcare.

The company is well known for its top products such as antibiotics, anti-malarials, cardiovascular, and anti-diabetic drugs. Its popular brands include Aurolife, Aurocare, Aurochem, and Aurovit. Aurobindo Pharma is one of the largest manufacturers of generic drugs in India, with a presence in over 150 countries worldwide.

Revenue: ₹9,105.82Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1,032.03Cr as on June 2026 (Q1 FY27)
Listing date: 19 Oct, 1995
Chairperson Name: K Ragunathan
OrganisationAurobindo Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOK Ragunathan
E-voting on sharesClick here to vote

FAQs

What is Aurobindo Pharma share price today?

Aurobindo Pharma share price today stands at ₹1681.4 as on at the close of the market. Aurobindo Pharma share today touched a day high of ₹1687 and a low of ₹1647.2.

What is the 52 week high and 52 week low range for Aurobindo Pharma share?

Aurobindo Pharma touched a 52 week high of ₹1740 and a 52 week low of ₹1081.4. Aurobindo Pharma share price today i.e. is closed at ₹1681.4, which is -3.37% down from its 52 week high and 55.48% up from its 52 week low.

What is Aurobindo Pharma's market capitalisation today?

Aurobindo Pharma market capitalisation is ₹96,744.04 Cr as on .

How to buy Aurobindo Pharma shares?

To buy Aurobindo Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AUROPHARMA or Aurobindo Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aurobindo Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aurobindo Pharma trading volume today?

Aurobindo Pharma trading volume is 9.53L as on . This means that 9.53L shares of Aurobindo Pharma were bought and sold on the stock market during today's trading session.